{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:26:34Z","timestamp":1781796394336,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ecl.2014.10.014","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T05:48:30Z","timestamp":1415080110000},"page":"171-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Pituitary Diseases and Bone"],"prefix":"10.1016","volume":"44","author":[{"given":"Gherardo","family":"Mazziotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Chiavistelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2014.10.014_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12020-011-9570-2","article-title":"New understanding and treatments for osteoporosis","volume":"41","author":"Mazziotti","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.ecl.2014.10.014_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2014.10.014_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12020-012-9626-y","article-title":"Further evidence that FSH causes bone loss independently of low estrogen","volume":"412","author":"Iqbal","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.ecl.2014.10.014_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1210\/jc.2012-2778","article-title":"Effects of recombinant follicle-stimulating hormone on bone turnover markers in infertile women undergoing in\u00a0vitro fertilization procedure","volume":"981","author":"Omodei","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2014.10.014_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jcb.22161","article-title":"Evidence for direct effects of prolactin on human osteoblasts: inhibition of cell growth and mineralization","volume":"107","author":"Seriwatanachai","year":"2009","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.ecl.2014.10.014_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11102-005-1051-2","article-title":"Cushing\u2019s syndrome and bone","volume":"7","author":"Mancini","year":"2004","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2014.10.014_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrendo.2013.5","article-title":"Glucocorticoids and the regulation of growth hormone secretion","volume":"95","author":"Mazziotti","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ecl.2014.10.014_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1530\/eje.0.1330646","article-title":"Influence of thyroid hormones on the regulation of growth hormone secretion","volume":"133","author":"Giustina","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2014.10.014_bib9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1359\/JBMR.041126","article-title":"Recombinant human TSH modulates in\u00a0vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma","volume":"20","author":"Mazziotti","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2014.10.014_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bone.2009.10.031","article-title":"Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density","volume":"46","author":"Mazziotti","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2014.10.014_bib11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1210\/jcem.83.3.4674","article-title":"Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males","volume":"83","author":"Di Somma","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2014.10.014_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11102-007-0064-4","article-title":"Bone density in women with prolactinoma treated with dopamine agonists","volume":"11","author":"Naliato","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2014.10.014_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1365-2265.2000.00902.x","article-title":"Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization","volume":"52","author":"Colao","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2014.10.014_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/jcem-67-1-124","article-title":"Effects of prolactin and estrogen deficiency in amenorrheic bone loss","volume":"67","author":"Klibanski","year":"1988","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2014.10.014_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.0300-0664.2001.01464.x","article-title":"Fracture risk is increased in patients with GH deficiency or untreated prolactinomas\u2014a case-control study","volume":"56","author":"Vestergaard","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2014.10.014_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12020-011-9462-5","article-title":"Vertebral fractures in males with prolactinoma","volume":"39","author":"Mazziotti","year":"2011","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.ecl.2014.10.014_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11102-011-0293-4","article-title":"High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas","volume":"14","author":"Mazziotti","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2014.10.014_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12020-012-9691-2","article-title":"New advances in imaging osteoporosis and its complications","volume":"42","author":"Griffith","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.ecl.2014.10.014_bib19","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJM198608283150903","article-title":"Increase in bone mass after treatment of hyperprolactinemic amenorrhea","volume":"315","author":"Klibanski","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2014.10.014_bib20","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1359\/JBMR.050603","article-title":"Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women","volume":"20","author":"Bonadonna","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2014.10.014_bib21","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2008-0791","article-title":"Prevalence of vertebral fractures in men with acromegaly","volume":"93","author":"Mazziotti","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2014.10.014_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2265.2008.03322.x","article-title":"Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study","volume":"70","author":"Battista","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2014.10.014_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/EJE-10-1005","article-title":"High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly","volume":"164","author":"Wassenaar","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2014.10.014_bib24","first-page":"37","article-title":"Prevalence of osteoporosis and vertebral fractures in acromegalic patients","volume":"8","author":"Padova","year":"2011","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.ecl.2014.10.014_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jocd.2012.06.002","article-title":"Vertebral fracture assessment in acromegaly","volume":"16","author":"Madeira","year":"2013","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.ecl.2014.10.014_bib26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/cen.12262","article-title":"FRAX score in acromegaly: does it tell the whole story?","volume":"80","author":"Brzana","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2014.10.014_bib27","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1210\/jc.2013-1460","article-title":"Vertebral fractures in patients with acromegaly: a 3-year prospective study","volume":"98","author":"Mazziotti","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2014.10.014_bib28","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1210\/jc.2013-2695","article-title":"Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study","volume":"98","author":"Claessen","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2014.10.014_bib29","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/BF03349164","article-title":"Diagnosis and treatment of acromegaly complications","volume":"26","author":"Giustina","year":"2003","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.ecl.2014.10.014_bib30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","article-title":"A\u00a0consensus on the diagnosis and treatment of acromegaly complications","volume":"16","author":"Melmed","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2014.10.014_bib31","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.ecl.2014.10.014_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1460051","article-title":"Increased risk of osteoporotic fractures in patients with Cushing's syndrome","volume":"146","author":"Vestergaard","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2014.10.014_bib33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00198-013-2520-5","article-title":"Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants","volume":"25","author":"Trementino","year":"2014","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.ecl.2014.10.014_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00198-013-2588-y","article-title":"Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?","volume":"25","author":"Scillitani","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2014.10.014_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11102-011-0306-3","article-title":"Spontaneous recovery of bone mass after cure of endogenous hypercortisolism","volume":"15","author":"Randazzo","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2014.10.014_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2147\/TCRM.S12952","article-title":"Treatment of Cushing disease: overview and recent findings","volume":"6","author":"Mancini","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ecl.2014.10.014_bib37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2265.1998.00486.x","article-title":"Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing\u2019s disease","volume":"48","author":"Di Somma","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2014.10.014_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11102-006-0410-y","article-title":"Growth hormone deficiency in the adult","volume":"9","author":"Doga","year":"2006","journal-title":"Pituitary"},{"issue":"8 Suppl","key":"10.1016\/j.ecl.2014.10.014_bib39","first-page":"18","article-title":"GH deficiency in the adult and bone","volume":"28","author":"Doga","year":"2005","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.ecl.2014.10.014_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2265.2009.03686.x","article-title":"Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence","volume":"72","author":"H\u00f6gler","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ecl.2014.10.014_bib41","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1210\/jc.2005-0897","article-title":"A\u00a0densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency","volume":"91","author":"Murray","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2014.10.014_bib42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","article-title":"The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density","volume":"16","author":"Wuster","year":"2001","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2014.10.014_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1530\/eje.0.1370240","article-title":"Increased fracture frequency in adult patients with hypopituitarism and GH deficiency","volume":"137","author":"Rosen","year":"1997","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2014.10.014_bib44","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.060112","article-title":"Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy","volume":"21","author":"Mazziotti","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2014.10.014_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11102-007-0069-z","article-title":"Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency","volume":"11","author":"Mazziotti","year":"2008","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ecl.2014.10.014_bib46","first-page":"55","article-title":"Growth hormone and bone","volume":"19","author":"Ohlsson","year":"1998","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ecl.2014.10.014_bib47","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2013-3921","article-title":"Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis","volume":"99","author":"Barake","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2014.10.014_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/EJE-11-0558","article-title":"Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis","volume":"166","author":"Hazem","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2014.10.014_bib49","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1530\/EJE-14-0097","article-title":"Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism","volume":"170","author":"Mazziotti","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2014.10.014_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/EJE-10-0125","article-title":"Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency","volume":"163","author":"Mazziotti","year":"2010","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985291400108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985291400108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:39:27Z","timestamp":1760175567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985291400108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S088985291400108X"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2014.10.014","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pituitary Diseases and Bone","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2014.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}